Found 10 matching trials
Inetetamab in Combination With Pyrotinib in HER2 Mutant or Amplified Advanced Non-small Cell Lung Cancer PHASE1 This is a Phase 1, open-label study to evaluate the safety and the efficacy...
Show More Location
Sun Yat-Sen University Cancer Center
Learn More & Join Trial
Almonertinib Combined With Pyrotinib in the Treatment of Advanced NSCLC Patients With HER-2 Amplification/Mutation After EGFR-TKI Resistance PHASE2 This is a multicenter, open, phase II clinical trial to evaluate the safety...
Show More Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial
SHR-A1811 Combine With Pyrotinib for Locally Advanced/Metastatic HER2 Positive Breast Cancer PHASE2 The goal of this clinical trial is to learn if SHR-A1811 combine with Pyrot...
Show More Location
Multiple Locations
Learn More & Join Trial
Nab-paclitaxel in Combination With Pyrotinib in Postoperative Adjuvant Therapy for HER2-positive Breast Cancer PHASE2 This is a multicenter, open-label, single-arm, prospective, phase II study....
Show More Location
Multiple Locations
Learn More & Join Trial
The Dosing Regimen of Pyrotinib in HER2-positive Advanced First-line Breast Cancer: a Phase II Clinical Study PHASE2 Evaluate the safety and efficacy of Pyrotinib in the transition from low-do...
Show More Location
Jiangsu Provincial People's Hospital
Learn More & Join Trial
TKIs vs. Pertuzumab in HER2+ Breast Cancer Patients With Active Brain Metastases (HER2BRAIN) PHASE2 This is a prospective, randomized, 2-arm, Phrase 2, superiority and multice...
Show More Location
Peking University International Hospital
Learn More & Join Trial
A Multicenter, Prospective Study of Diarrhea Tolerance of Pyrotinib Combined With Trastumab and Taxane in the First-line Treatment of HER2-positive Advanced Breast Cancer PHASE2 To explore a reasonable and effective way to reduce the incidence of grade ...
Show More Location
Multiple Locations
Learn More & Join Trial
Precision Treatment of Recurrent/Metastatic Salivary Gland Carcinoma Guided by Molecular Typing PHASE2 Patients with salivary gland carcinoma were divided into groups according t...
Show More Learn More & Join Trial
Dalpiciclib, Anti-HER2 Therapy, and Endocrine Therapy for Hormone-Receptor-Positive, HER2-Positive Metastatic Breast Cancer PHASE2 Efficacy and Safety of Dalpiciclib Combined with Anti-HER2 Targeted Therapy...
Show More Location
Sun yat-Sen University Cancer Center, Guangzhou, Yuexiu District
Learn More & Join Trial
FUSCC Refractory TNBC Umbrella (FUTURE) PHASE1 This is a Phase Ib/II, open-label, multi-center umbrella study evaluating t...
Show More Location
Fudan University Shanghai Cancer Center
Learn More & Join Trial